Estrogenic and antiproliferative activities on MCF-7 human breast cancer cells by flavonoids

被引:159
|
作者
Le Bail, JC
Varnat, F
Nicolas, JC
Habrioux, G
机构
[1] Fac Pharm, Biochim Lab, UPRES EA 1085, F-87025 Limoges, France
[2] INSERM, U439, F-34090 Montpellier, France
关键词
MCF-7; cells; estrogen receptor; flavonoids; luciferase activity;
D O I
10.1016/S0304-3835(98)00141-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The interaction between the estrogen receptor and a variety of flavonoids was studied in the presence or absence of estradiol using a stably-transfected human boast cancer cell line (MVLN). On the other hand, flavonoids were evaluated for their effects on proliferation in estrogen-dependent (MCF-7) and independent (MDA-MB231) human breast cancer cells. We established a relationship structure-activity and determined regions and/or substituents essential for estrogenic or antiestrogenic activities. In contrast, we did not find the same relationship for cell proliferation. Among all flavonoids used, only 7-methoxyflavanone and 7,8-dihydroxyflavone at high concentrations (50 mu M) possess antiestrogenic and antiproliferative activities. These results suggest that two hydroxyls (in positions 7 and 8) or 7-methoxy substituents are essential for the antiestrogenic activity of flavonoids. However, it seems that flavonoids at high concentrations exert their antiproliferative activity through other estrogen receptor-independent mechanisms. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:209 / 216
页数:8
相关论文
共 50 条
  • [21] Estrogenic and antiestrogenic effects of raloxifene on collagen metabolism in breast cancer MCF-7 cells
    Wolczynski, S
    Surazynski, A
    Swiatecka, J
    Palka, J
    GYNECOLOGICAL ENDOCRINOLOGY, 2001, 15 (03) : 225 - 233
  • [22] Estrogenic activities of pyrethroid compounds in MCF-7 BUS cells.
    Han, S
    TOXICOLOGICAL SCIENCES, 2003, 72 : 90 - 91
  • [23] Comparison of the characteristic of estrogenic action patterns of β-HCH and heregulin β1 in MCF-7 human breast cancer cells
    Hatakeyama, M
    Zou, E
    Matsumura, F
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2002, 16 (05) : 209 - 219
  • [24] Antiestrogenic and antiproliferative potency of secoisolariciresinol diglucoside derivatives on MCF-7 breast cancer cells
    Scherbakov, Alexander M.
    Stasevich, Olga V.
    Salnikova, Diana I.
    Andreeva, Olga E.
    Mikhaevich, Ekaterina I.
    NATURAL PRODUCT RESEARCH, 2021, 35 (24) : 6099 - 6105
  • [25] Antiproliferative effects of isoprenoids from Sarcophyton glaucum on breast cancer MCF-7 cells
    Ghandourah, Mohamed A.
    Alarif, Walied M.
    Abdel-Lateff, Ahmed
    Al-Footy, Khalid O.
    Halid, Mohamed
    Al-Lihaibi, Sultan S.
    Alorfi, Hajer S.
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2017, 16 (03) : 501 - 507
  • [26] Enhanced and Selective Antiproliferative Activity of Methotrexate-Functionalized-Nanocapsules to Human Breast Cancer Cells (MCF-7)
    de Oliveira, Catiuscia P.
    Buttenbender, Sabrina L.
    Prado, Willian A.
    Beckenkamp, Aline
    Asbahr, Ana C.
    Buffon, Andreia
    Guterres, Silvia S.
    Pohlmann, Adriana R.
    NANOMATERIALS, 2018, 8 (01):
  • [27] Curcumin enhanced antiproliferative effect of mitomycin C in human breast cancer MCF-7 cells in vitro and in vivo
    Qian-mei Zhou
    Xiu-feng Wang
    Xin-jun Liu
    Hui Zhang
    Yi-yu Lu
    Shi-bing Su
    Acta Pharmacologica Sinica, 2011, 32 : 1402 - 1410
  • [28] Rapamycin enhances the antiproliferative effect of transforming growth factor-β on MCF-7 human breast cancer cells
    Wang, Guoping
    Yin, Tao
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 14 (01) : 748 - 752
  • [29] Curcumin enhanced antiproliferative effect of mitomycin C in human breast cancer MCF-7 cells in vitro and in vivo
    Zhou, Qian-mei
    Wang, Xiu-feng
    Liu, Xin-jun
    Zhang, Hui
    Lu, Yi-yu
    Su, Shi-bing
    ACTA PHARMACOLOGICA SINICA, 2011, 32 (11) : 1402 - 1410
  • [30] ANTIPROLIFERATIVE ACTIVITY OF A SERIES OF NOVEL CYCLOPROPYL ANTIESTROGENS ON MCF-7 HUMAN BREAST-CANCER CELLS IN CULTURE
    JAIN, PT
    PENTO, JT
    MAGARIAN, RA
    GRAVES, DC
    ANTI-CANCER DRUGS, 1991, 2 (05) : 487 - 493